Loading clinical trials...
Loading clinical trials...
The purpose of this study is to better understand the safety, tolerability and distribution of CNTO 328 in the bloodstream.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centocor, Inc.
NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more
NCT04895709 · Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, and more
NCT07227415 · Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, and more
NCT07166445 · Carcinoma, Renal Cell, Diagnostic Imaging, and more
NCT05127824 · Carcinoma, Renal Cell
Brno
Hradec nad Svitavou
Caen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions